Document:

Exhibit 10.3

    

    

    REGISTRATION AND STOCKHOLDER RIGHTS AGREEMENT

    

    

    THIS REGISTRATION AND STOCKHOLDER RIGHTS AGREEMENT (this “Agreement”), dated as of December 22, 2020, is made and entered into by and among Healthcare Services Acquisition Corporation, a Delaware corporation (the “Company”), Healthcare Services Acquisition Holdings LLC, a Delaware limited liability company (the “Sponsor”), and the undersigned parties listed under Holder on the signature page hereto (each such party, together with the Sponsor, members of the Sponsor and any person or entity who hereafter
      becomes a party to this Agreement pursuant to Section 6.2 of this Agreement, a “Holder” and collectively the “Holders”).

    

    

    RECITALS

    

    

    WHEREAS, the Company and the Sponsor
      have entered into that certain Securities Subscription Agreement, dated as of September 2, 2020, pursuant to which the Sponsor purchased an aggregate of 8,625,000 shares of the Company’s Class B common stock, par value $0.0001 per share (the “Class B Common Stock”);

    

    

    WHEREAS, the Sponsor subsequently
      transferred an aggregate of 90,000 Founder Shares to certain of the other Holders and forfeited 1,725,000 Founder Shares to the Company;

    

    

    WHEREAS, on December 22, 2020, the
      Company declared a stock dividend (the “Dividend”) with respect to the Class B Common Stock of 1,380,000 shares of Class B
      Common Stock, and each of the Company’s independent directors, Michael P. Donovan, Brian T. Griffin and Jeanne L. Manischewitz, renounced any interest in such Dividend on December 22, 2020, resulting in (i) the Sponsor holding an aggregate of
      8,190,000 shares of Class B Common Stock (up to 1,080,000 of which are subject to forfeiture by the Sponsor if the over-allotment option in connection with the Company’s initial public offering is not exercised in full) and (ii) there being an
      aggregate of 8,280,000 shares of Class B Common Stock outstanding (the “Founder Shares”);

    

    

    WHEREAS, the Founder Shares are
      convertible into shares of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), at the time of
      the initial Business Combination (as defined below) on a one-for-one basis, subject to adjustment, on the terms and conditions provided in the Company’s amended and restated certificate of incorporation, as may be amended from time to time;

    

    

    WHEREAS, on December 22, 2020, the
      Company and the Sponsor entered into that certain Warrant Purchase Agreement, pursuant to which the Sponsor agreed to purchase 5,626,000 warrants (or up to 6,252,400 warrants pro rata to the extent that the over-allotment option in connection with
      the Company’s initial public offering is exercised) (together with all other warrants issued by the Company to the Sponsor on substantially the same terms, the “Sponsor Private Placement Warrants”), in a private placement transaction occurring
      simultaneously with the closing of the Company’s initial public offering, each Sponsor Private Placement Warrant entitling the holder to purchase one share of Common Stock at an exercise price of $11.50 per share;

    

    

    WHEREAS, on October 7, 2020, the
      Company and certain funds and accounts managed by BlackRock, Inc. (collectively, the “Anchor Investor”) entered into that
      certain Subscription Agreement, as amended by Amendment No. 1, dated as of December 11, 2020 and Amendment No. 2 dated as of December 22, 2020, pursuant to which the Anchor Investor agreed to purchase an aggregate of 2,134,000 warrants (or up to
      2,371,600 warrants pro rata to the extent that the over-allotment option in connection with the Company’s initial public offering is exercised) (the “Anchor Private Placement Warrants”, together with the Sponsor Private Placement Warrants, the “Private
        Placement Warrants”), in a private placement transaction occurring simultaneously with the closing of the Company’s initial public offering, each Anchor Private Placement Warrant entitling the holder to purchase one share of Common Stock at
      an exercise price of $11.50 per share; and

    

    

    WHEREAS, the Company and the Holders
      desire to enter into this Agreement, pursuant to which the Company shall grant the Holders certain registration rights with respect to certain securities of the Company, as set forth in this Agreement.

    

    

    
      

      
        

      

    

    NOW, THEREFORE, in consideration of the mutual representations, covenants and agreements contained herein, and certain other good and valuable consideration, the receipt and
      sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:

    

    

    ARTICLE I

    DEFINITIONS

    

    

    1.1 Definitions. The terms defined in this Article I shall, for all purposes of this Agreement, have the respective meanings set forth below:

    

    

    “Adverse Disclosure”
      shall mean any public disclosure of material non-public information, which disclosure, in the good faith judgment of the Chief Executive Officer or any principal financial officer of the Company, after consultation with counsel to the Company, (i)
      would be required to be made in any Registration Statement or Prospectus in order for the applicable Registration Statement or Prospectus not to contain any untrue statement of a material fact or omit to state a material fact necessary to make the
      statements contained therein (in the case of any prospectus and any preliminary prospectus, in the light of the circumstances under which they were made) not misleading, (ii) would not be required to be made at such time if the Registration Statement
      were not being filed, and (iii) the Company has a bona fide business purpose for not making such information public.

    

    

    “Agreement”
      shall have the meaning given in the Preamble.

    

    

    “Anchor Investor”
      shall have the meaning given in the Recitals hereto.

    

    

    “Anchor Private
        Placement Warrants” shall have the meaning given in the Recitals hereto.

    

    

    “Board” shall
      mean the Board of Directors of the Company.

    

    

    “Business Combination”
      shall mean any merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses, involving the Company.

    

    

    “Class B Common Stock”
      shall have the meaning given in the Recitals hereto.

    

    

    “Commission”
      shall mean the U.S. Securities and Exchange Commission.

    

    

    “Common Stock”
      shall have the meaning given in the Recitals hereto.

    

    

    “Company” shall
      have the meaning given in the Preamble.

    

    

    “Demand Registration”
      shall have the meaning given in subsection 2.1.1.

    

    

    “Demanding Holder”
      shall have the meaning given in subsection 2.1.1.

    

    

    “Exchange Act”
      shall mean the Securities Exchange Act of 1934, as amended.

    

    

    “Form S-1” shall
      have the meaning given in subsection 2.1.1.

    

    

    “Form S-3” shall
      have the meaning given in subsection 2.3.

    

    

    “Founder Shares”
      shall have the meaning given in the Recitals hereto and shall be deemed to include the shares of Common Stock issuable upon conversion thereof.

    

    

    “Founder Shares Lock-Up
        Period” shall mean, with respect to the Founder Shares, the period ending on the earlier of (A) one year after the completion of the Company’s initial Business Combination or (B) subsequent to the Business Combination, (x) if the last
      reported sale price of the Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least
      150 days after the Company’s initial Business Combination or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders
      having the right to exchange their shares of Common Stock for cash, securities or other property.

    

    

    
      

      
        

      

    

    “Holders” shall
      have the meaning given in the Preamble.

    

    

    “Insider Letter”
      shall mean that certain letter agreement, dated as of the date hereof, by and among the Company, the Sponsor, each member of the Sponsor and each of the Company’s executive officers, directors and director nominees.

    

    

    “Maximum Number of
        Securities” shall have the meaning given in subsection 2.1.4.

    

    

    “Misstatement”
      shall mean an untrue statement of a material fact or an omission to state a material fact required to be stated in a Registration Statement or Prospectus, or necessary to make the statements in a Registration Statement not misleading or, in the case
      of a Prospectus, not misleading in the light of the circumstances under which they were made.

    

    

    “Nominee” shall
      have the meaning given in subsection 5.1.1.

    

    

    “Permitted Transferees”
      shall mean any person or entity to whom a Holder of Registrable Securities is permitted to transfer such Registrable Securities prior to the expiration of the Founder Shares Lock-Up Period or Private Placement Lock-Up Period, as the case may be,
      under the Insider Letter and any other applicable agreement between such Holder and the Company, and to any transferee thereafter.

    

    

    “Piggyback Registration”
      shall have the meaning given in subsection 2.2.1.

    

    

    “Private Placement
        Lock-Up Period” shall mean, with respect to Private Placement Warrants that are held by the initial purchasers of such Private Placement Warrants or their Permitted Transferees, and any of the shares of Common Stock issued or issuable upon
      the exercise or conversion of the Private Placement Warrants and that are held by the initial purchasers of the Private Placement Warrants or their Permitted Transferees, the period ending 30 days after the completion of the Company’s initial
      Business Combination.

    

    

    “Private Placement
        Warrants” shall have the meaning given in the Recitals hereto.

    

    

    “Pro Rata” shall
      have the meaning given in subsection 2.1.4.

    

    

    “Prospectus”
      shall mean the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended by any and all post-effective amendments and including all material incorporated by reference in such prospectus.

    

    

    “Registrable Security”
      shall mean (a) the shares of Common Stock issued or issuable upon the conversion of any Founder Shares, (b) the Private Placement Warrants (including any shares of the Common Stock issued or issuable upon the exercise of any such Private Placement
      Warrants), (c) any outstanding shares of Common Stock or any other equity security (including the shares of Common Stock issued or issuable upon the exercise of any other equity security) of the Company held by a Holder as of the date of this
      Agreement or purchased in the IPO or at any time thereafter, (d) any equity securities (including the shares of Common Stock issued or issuable upon the exercise of any such equity security) of the Company issuable upon conversion of any working
      capital loans in an amount up to $2,000,000 made to the Company by a Holder, and (e) any other equity security of the Company issued or issuable with respect to any such shares of Common Stock by way of a stock dividend or stock split or in
      connection with a combination of shares, recapitalization, merger, consolidation or reorganization; provided, however, that, as to any particular Registrable Security, such securities shall cease to be Registrable Securities when: (A) a Registration Statement with respect to the sale of such securities shall
      have become effective under the Securities Act and such securities shall have been sold, transferred, disposed of or exchanged in accordance with such Registration Statement; (B) such securities shall have been otherwise transferred, new certificates
      for such securities not bearing a legend restricting further transfer shall have been delivered by the Company and subsequent public distribution of such securities shall not require registration under the Securities Act; (C) such securities shall
      have ceased to be outstanding; (D) such securities may be sold without registration pursuant to Rule 144 promulgated under the Securities Act (or any successor rule promulgated thereafter by the Commission) (but with no volume or other restrictions
      or limitations); or (E) such securities have been sold to, or through, a broker, dealer or underwriter in a public distribution or other public securities transaction.

    

    

    
      

      
        

      

    

    “Registration”
      shall mean a registration effected by preparing and filing a registration statement or similar document in compliance with the requirements of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration
      statement becoming effective.

    

    

    “Registration Expenses”
      shall mean the out-of-pocket expenses of a Registration, including, without limitation, the following:

    

    

    (A) all registration and filing fees (including fees with respect to filings required to be made with the Financial Industry Regulatory
      Authority, Inc.) and any securities exchange on which the Common Stock is then listed;

    

    

    (B) fees and expenses of compliance with securities or blue sky laws (including reasonable fees and disbursements of counsel for the
      Underwriters in connection with blue sky qualifications of Registrable Securities);

    

    

    (C) printing, messenger, telephone and delivery expenses;

    

    

    (D) reasonable fees and disbursements of counsel for the Company;

    

    

    (E) reasonable fees and disbursements of all independent registered public accountants of the Company incurred specifically in connection
      with such Registration; and

    

    

    (F) reasonable fees and expenses of one (1) legal counsel selected by the Demanding Holder initiating a Demand Registration to be
      registered for offer and sale in the applicable Registration.

    

    

    “Registration Statement”
      shall mean any registration statement that covers the Registrable Securities pursuant to the provisions of this Agreement, including the Prospectus included in such registration statement, amendments (including post-effective amendments) and
      supplements to such registration statement, and all exhibits to and all material incorporated by reference in such registration statement.

    

    

    “Requesting Holder”
      shall have the meaning given in subsection 2.1.1.

    

    

    “Securities Act”
      shall mean the Securities Act of 1933, as amended.

    

    

    “Sponsor” shall
      have the meaning given in the Preamble.

    

    

    “Sponsor Director”
      means an individual elected to the Board that has been nominated pursuant to Section 5.1.

    

    

    “Underwriter”
      shall mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering and not as part of such dealer’s market-making activities.

    

    

    “Underwritten
        Registration” or “Underwritten Offering” shall mean a Registration in which securities of the Company are sold to an
      Underwriter in a firm commitment underwriting for distribution to the public.

    

    

    
      

      
        

      

    

    ARTICLE II

    REGISTRATIONS

    

    

    2.1 Demand Registration.

    

    

    2.1.1 Request for Registration. Subject to the
      provisions of subsection 2.1.4 and Section 2.4 hereof, at any time
      and from time to time on or after the date the Company consummates the Business Combination, the Holders of at least a majority in interest of the then-outstanding number of Registrable Securities (the “Demanding Holders”) may make a written demand for Registration of all or part of its Registrable Securities, which written demand shall describe the amount and type of
      securities to be included in such Registration and the intended method(s) of distribution thereof (such written demand a “Demand
        Registration”). The Company shall, within ten (10) days of the Company’s receipt of the Demand Registration, notify, in writing, all other Holders of Registrable Securities of such demand, and each Holder of Registrable Securities who
      thereafter wishes to include all or a portion of such Holder’s Registrable Securities in a Registration pursuant to a Demand Registration (each such Holder that includes all or a portion of such Holder’s Registrable Securities in such Registration, a
      “Requesting Holder”) shall so notify the Company, in writing, within five (5) days after the receipt by the Holder of the
      notice from the Company. Upon receipt by the Company of any such written notification from a Requesting Holder(s) to the Company, such Requesting Holder(s) shall be entitled to have their Registrable Securities included in a Registration pursuant to
      a Demand Registration and the Company shall effect, as soon thereafter as practicable, but not more than forty five (45) days immediately after the Company’s receipt of the Demand Registration, the Registration of all Registrable Securities requested
      by the Demanding Holder and Requesting Holders pursuant to such Demand Registration. Under no circumstances shall the Company be obligated to effect more than an aggregate of three (3) Registrations pursuant to a Demand Registration under this subsection 2.1.1 with respect to any or all Registrable Securities; provided,
      however, that a Registration shall not be counted for such purposes unless a Form S-1 or any similar long-form registration statement that may be available at
      such time (“Form S-1”) has become effective and all of the Registrable Securities requested by the Requesting Holders to be
      registered on behalf of the Requesting Holders in such Form S-1 Registration have been sold, in accordance with Section 3.1 of this Agreement.

    

    

    2.1.2 Effective Registration. Notwithstanding
      the provisions of subsection 2.1.1 above or any other part of this Agreement, a Registration pursuant to a Demand Registration shall not count as a
      Registration unless and until (i) the Registration Statement filed with the Commission with respect to a Registration pursuant to a Demand Registration has been declared effective by the Commission and (ii) the Company has complied with all of its
      obligations under this Agreement with respect thereto; provided, further,
      that if, after such Registration Statement has been declared effective, an offering of Registrable Securities in a Registration pursuant to a Demand Registration is subsequently interfered with by any stop order or injunction of the Commission,
      federal or state court or any other governmental agency the Registration Statement with respect to such Registration shall be deemed not to have been declared effective, unless and until, (i) such stop order or injunction is removed, rescinded or
      otherwise terminated and (ii) a majority-in-interest of the Demanding Holders initiating such Demand Registration thereafter affirmatively elect within five (5) days to continue with such Registration and accordingly notify the Company in writing of
      such election within such five (5)-day period; provided, further,
      that the Company shall not be obligated or required to file another Registration Statement until the Registration Statement that has been previously filed with respect to a Registration pursuant to a Demand Registration becomes effective or is
      subsequently terminated.

    

    

    2.1.3 Underwritten Offering. Subject to the
      provisions of subsection 2.1.4 and Section 2.4 hereof, if a
      majority-in-interest of the Demanding Holders so advise the Company as part of its Demand Registration that the offering of the Registrable Securities pursuant to such Demand Registration shall be in the form of an Underwritten Offering, then the
      right of such Demanding Holder or Requesting Holder (if any) to include its Registrable Securities in such Registration shall be conditioned upon such Holder’s participation in such Underwritten Offering and the inclusion of such Holder’s Registrable
      Securities in such Underwritten Offering to the extent provided herein. All such Holders proposing to distribute their Registrable Securities through an Underwritten Offering under this subsection 2.1.3 shall enter into an underwriting agreement in customary form with the Underwriter(s) selected for such Underwritten Offering by the majority-in-interest of the Demanding Holders initiating the Demand
      Registration.

    

    

    2.1.4 Reduction of Underwritten Offering. If
      the managing Underwriter or Underwriters in an Underwritten Registration pursuant to a Demand Registration, in good faith, advises the Company, the Demanding Holders and the Requesting Holders (if any) in writing that the dollar amount or number of
      Registrable Securities that the Demanding Holders and the Requesting Holders (if any) desire to sell, taken together with all other Common Stock or other equity securities that the Company desires to sell and the Common Stock, if any, as to which a
      Registration has been requested pursuant to separate written contractual piggy-back registration rights held by any other stockholders who desire to sell, exceeds the maximum dollar amount or maximum number of equity securities that can be sold in
      the Underwritten Offering without adversely affecting the proposed offering price, the timing, the distribution method, or the probability of success of such offering (such maximum dollar amount or maximum number of such securities, as applicable,
      the “Maximum Number of Securities”), then the Company shall include in such Underwritten Offering, as follows: (i) first, the
      Registrable Securities of the Demanding Holders and the Requesting Holders (if any) (pro rata based on the respective number of Registrable Securities that each Demanding Holder and Requesting Holder (if any) has requested be included in such
      Underwritten Registration and the aggregate number of Registrable Securities that the Demanding Holders and Requesting Holders have requested be included in such Underwritten Registration (such proportion is referred to herein as “Pro Rata”)) that can be sold without exceeding the Maximum Number of Securities; (ii) second, to the extent that the Maximum Number
      of Securities has not been reached under the foregoing clause (i), the Common Stock or other equity securities that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; and (iii) third, to the extent that
      the Maximum Number of Securities has not been reached under the foregoing clauses (i) and (ii), the Common Stock or other equity securities of other persons or entities that the Company is obligated to register in a Registration pursuant to separate
      written contractual arrangements with such persons and that can be sold without exceeding the Maximum Number of Securities.

    

    

    
      

      
        

      

    

    2.1.5 Demand Registration Withdrawal. A
      majority-in-interest of the Demanding Holders initiating a Demand Registration or a majority-in-interest of the Requesting Holders (if any), pursuant to a Registration under subsection 2.1.1 shall have the right to withdraw from a Registration pursuant to such Demand Registration for any or no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any)
      of their intention to withdraw from such Registration prior to the effectiveness of the Registration Statement filed with the Commission with respect to the Registration of their Registrable Securities pursuant to such Demand Registration.
      Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with a Registration pursuant to a Demand Registration prior to its withdrawal under this subsection 2.1.5.

    

    

    2.2 Piggyback Registration.

    

    

    2.2.1 Piggyback Rights. If, at any time on or
      after the date the Company consummates a Business Combination, the Company proposes to file a Registration Statement under the Securities Act with respect to an offering of equity securities, or securities or other obligations exercisable or
      exchangeable for, or convertible into equity securities, for its own account or for the account of stockholders of the Company (or by the Company and by the stockholders of the Company including, without limitation, pursuant to Section 2.1 hereof), other than a Registration Statement (i) filed in connection with any employee stock option or other benefit plan, (ii) for an exchange offer
      or offering of securities solely to the Company’s existing stockholders, (iii) for an offering of debt that is convertible into equity securities of the Company or (iv) for a dividend reinvestment plan, then the Company shall give written notice of
      such proposed filing to all of the Holders of Registrable Securities as soon as practicable but not less than ten (10) days before the anticipated filing date of such Registration Statement, which notice shall (A) describe the amount and type of
      securities to be included in such offering, the intended method(s) of distribution, and the name of the proposed managing Underwriter or Underwriters, if any, in such offering, and (B) offer to all of the Holders of Registrable Securities the
      opportunity to register the sale of such number of Registrable Securities as such Holders may request in writing within five (5) days after receipt of such written notice (such Registration, a “Piggyback Registration”). The Company shall, in good faith, cause such Registrable Securities to be included in such Piggyback Registration and shall use its best efforts to cause
      the managing Underwriter or Underwriters of a proposed Underwritten Offering to permit the Registrable Securities requested by the Holders pursuant to this subsection
          2.2.1 to be included in a Piggyback Registration on the same terms and conditions as any similar securities of the Company included in such Registration and to permit the sale or other disposition of such Registrable Securities in
      accordance with the intended method(s) of distribution thereof. All such Holders proposing to distribute their Registrable Securities through an Underwritten Offering under this subsection 2.2.1 shall enter into an underwriting agreement in customary form with the Underwriter(s) selected for such Underwritten Offering by the Company.

    

    

    2.2.2 Reduction of Piggyback Registration. If
      the managing Underwriter or Underwriters in an Underwritten Registration that is to be a Piggyback Registration, in good faith, advises the Company and the Holders of Registrable Securities participating in the Piggyback Registration in writing that
      the dollar amount or number of the shares of Common Stock that the Company desires to sell, taken together with (i) the Common Stock, if any, as to which Registration has been demanded pursuant to separate written contractual arrangements with
      persons or entities other than the Holders of Registrable Securities hereunder, (ii) the Registrable Securities as to which registration has been requested pursuant to Section
          2.2 hereof, and (iii) the Common Stock, if any, as to which Registration has been requested pursuant to separate written contractual piggy-back registration rights of other stockholders of the Company, exceeds the Maximum Number of
      Securities, then:

    

    

    
      

      
        

      

    

    (a) If the Registration is undertaken for the Company’s account, the Company shall include in any such Registration (A) first, the Common
      Stock or other equity securities that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause
      (A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.2.1 hereof, Pro Rata,
      which can be sold without exceeding the Maximum Number of Securities; and (C) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A) and (B), the Common Stock, if any, as to which Registration
      has been requested pursuant to written contractual piggy-back registration rights of other stockholders of the Company, which can be sold without exceeding the Maximum Number of Securities;

    

    

    (b) If the Registration is pursuant to a request by persons or entities other than the Holders of Registrable Securities, then the Company
      shall include in any such Registration (A) first, the Common Stock or other equity securities, if any, of such requesting persons or entities, other than the Holders of Registrable Securities, which can be sold without exceeding the Maximum Number of
      Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.2.1, Pro Rata, which can be sold without exceeding the Maximum Number of Securities; (C) third, to the extent that the Maximum Number of Securities
      has not been reached under the foregoing clauses (A) and (B), the Common Stock or other equity securities that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; and (D) fourth, to the extent that the
      Maximum Number of Securities has not been reached under the foregoing clauses (A), (B) and (C), the Common Stock or other equity securities for the account of other persons or entities that the Company is obligated to register pursuant to separate
      written contractual arrangements with such persons or entities, which can be sold without exceeding the Maximum Number of Securities.

    

    

    2.2.3 Piggyback Registration Withdrawal. Any
      Holder of Registrable Securities shall have the right to withdraw from a Piggyback Registration for any or no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) of his, her or its intention to
      withdraw from such Piggyback Registration prior to the effectiveness of the Registration Statement filed with the Commission with respect to such Piggyback Registration. The Company (whether on its own good faith determination or as the result of a
      request for withdrawal by persons pursuant to separate written contractual obligations) may withdraw a Registration Statement filed with the Commission in connection with a Piggyback Registration at any time prior to the effectiveness of such
      Registration Statement. Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with the Piggyback Registration prior to its withdrawal under this subsection 2.2.3.

    

    

    2.2.4 Unlimited Piggyback Registration Rights.
      For purposes of clarity, any Registration effected pursuant to Section 2.2 hereof shall not be counted as a Registration pursuant to a Demand Registration
      effected under Section 2.1 hereof.

    

    

    2.3 Registrations on Form S-3. The Holders of
      Registrable Securities may at any time, and from time to time, request in writing that the Company, pursuant to Rule 415 under the Securities Act (or any successor rule promulgated thereafter by the Commission), register the resale of any or all of
      their Registrable Securities on Form S-3 or any similar short form registration statement that may be available at such time (“Form
        S-3”); provided, however, that the Company shall not be
      obligated to effect such request through an Underwritten Offering. Within five (5) days of the Company’s receipt of a written request from a Holder or Holders of Registrable Securities for a Registration on Form S-3, the Company shall promptly give
      written notice of the proposed Registration on Form S-3 to all other Holders of Registrable Securities, and each Holder of Registrable Securities who thereafter wishes to include all or a portion of such Holder’s Registrable Securities in such
      Registration on Form S-3 shall so notify the Company, in writing, within ten (10) days after the receipt by the Holder of the notice from the Company. As soon as practicable thereafter, but not more than twelve (12) days after the Company’s initial
      receipt of such written request for a Registration on Form S-3, the Company shall register all or such portion of such Holder’s Registrable Securities as are specified in such written request, together with all or such portion of Registrable
      Securities of any other Holder or Holders joining in such request as are specified in the written notification given by such Holder or Holders; provided, however, that the Company shall not be obligated to effect any such Registration pursuant to this Section 2.3 if (i) a Form S-3 is not available for such offering; or (ii) the Holders of Registrable Securities, together with the Holders of any other equity securities of the Company entitled to inclusion in such
      Registration, propose to sell the Registrable Securities and such other equity securities (if any) at any aggregate price to the public of less than $10,000,000.

    

    

    
      

      
        

      

    

    2.4 Restrictions on Registration Rights. If (A)
      during the period starting with the date sixty (60) days prior to the Company’s good faith estimate of the date of the filing of, and ending on a date one hundred and twenty (120) days after the effective date of, a Company initiated Registration and
      provided that the Company has delivered written notice to the Holders prior to receipt of a Demand Registration pursuant to subsection 2.1.1 and it continues
      to actively employ, in good faith, all reasonable efforts to cause the applicable Registration Statement to become effective; (B) the Holders have requested an Underwritten Registration and the Company and the Holders are unable to obtain the
      commitment of underwriters to firmly underwrite the offer; or (C) in the good faith judgment of the Board such Registration would be seriously detrimental to the Company and the Board concludes as a result that it is essential to defer the filing of
      such Registration Statement at such time, then in each case the Company shall furnish to such Holders a certificate signed by the Chairman of the Board stating that in the good faith judgment of the Board it would be seriously detrimental to the
      Company for such Registration Statement to be filed in the near future and that it is therefore essential to defer the filing of such Registration Statement. In such event, the Company shall have the right to defer such filing for a period of not
      more than thirty (30) days; provided, however, that the Company
      shall not defer its obligation in this manner more than once in any 12-month period. Notwithstanding anything to the contrary contained in this Agreement, no Registration shall be effected or permitted and no Registration Statement shall become
      effective, with respect to any Registrable Securities held by any Holder, until after the expiration of the Founder Shares Lock-Up Period or the Private Placement Lock-Up Period, as the case may be.

    

    

    2.5 Waiver. Notwithstanding anything in this
      Agreement to the contrary, unless the Company is notified in writing to the contrary by the Anchor Investor, (A) the Anchor Investor hereby waives any and all rights (i) to receive notice of a Demand Registration relating to any Underwritten Offering
      as provided for in this Section 2 or (ii) to participate in any such Underwritten Offering, and (B) the Company hereby agrees not to notify the Anchor
      Investor of any Underwritten Offering or provide the Anchor Investor with any information relating thereto.

    

    

    ARTICLE III

    COMPANY PROCEDURES

    

    

    3.1 General Procedures. If at any time on or
      after the date the Company consummates a Business Combination the Company is required to effect the Registration of Registrable Securities, the Company shall use its best efforts to effect such Registration to permit the sale of such Registrable
      Securities in accordance with the intended plan of distribution thereof, and pursuant thereto the Company shall, as expeditiously as possible:

    

    

    3.1.1 prepare and file with the Commission as soon as practicable a Registration Statement with respect to such Registrable Securities and
      use its reasonable best efforts to cause such Registration Statement to become effective and remain effective until all Registrable Securities covered by such Registration Statement have been sold;

    

    

    3.1.2 prepare and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such
      supplements to the Prospectus, as may be reasonably requested by the Holders or any Underwriter of Registrable Securities or as may be required by the rules, regulations or instructions applicable to the registration form used by the Company or by
      the Securities Act or rules and regulations thereunder to keep the Registration Statement effective until all Registrable Securities covered by such Registration Statement are sold in accordance with the intended plan of distribution set forth in
      such Registration Statement or supplement to the Prospectus;

    

    

    
      

      
        

      

    

    3.1.3 prior to filing a Registration Statement or Prospectus, or any amendment or supplement thereto, furnish without charge to the
      Underwriters, if any, and the Holders of Registrable Securities included in such Registration, and such Holders’ legal counsel, copies of such Registration Statement as proposed to be filed, each amendment and supplement to such Registration
      Statement (in each case including all exhibits thereto and documents incorporated by reference therein), the Prospectus included in such Registration Statement (including each preliminary Prospectus), and such other documents as the Underwriters and
      the Holders of Registrable Securities included in such Registration or the legal counsel for any such Holders may request in order to facilitate the disposition of the Registrable Securities owned by such Holders;

    

    

    3.1.4 prior to any public offering of Registrable Securities, use its best efforts to (i) register or qualify the Registrable Securities
      covered by the Registration Statement under such securities or “blue sky” laws of such jurisdictions in the United States as the Holders of Registrable Securities included in such Registration Statement (in light of their intended plan of
      distribution) may request and (ii) take such action necessary to cause such Registrable Securities covered by the Registration Statement to be registered with or approved by such other governmental authorities as may be necessary by virtue of the
      business and operations of the Company and do any and all other acts and things that may be necessary or advisable to enable the Holders of Registrable Securities included in such Registration Statement to consummate the disposition of such
      Registrable Securities in such jurisdictions; provided, however,
      that the Company shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify or take any action to which it would be subject to general service of process or taxation in any such
      jurisdiction where it is not then otherwise so subject;

    

    

    3.1.5 cause all such Registrable Securities to be listed on each securities exchange or automated quotation system on which similar
      securities issued by the Company are then listed;

    

    

    3.1.6 provide a transfer agent or warrant agent, as applicable, and registrar for all such Registrable Securities no later than the
      effective date of such Registration Statement;

    

    

    3.1.7 advise each seller of such Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of the
      issuance of any stop order by the Commission suspending the effectiveness of such Registration Statement or the initiation or threatening of any proceeding for such purpose and promptly use its reasonable best efforts to prevent the issuance of any
      stop order or to obtain its withdrawal if such stop order should be issued;

    

    

    3.1.8 at least five (5) days prior to the filing of any Registration Statement or Prospectus or any amendment or supplement to such
      Registration Statement or Prospectus or any document that is to be incorporated by reference into such Registration Statement or Prospectus, furnish a copy thereof to each seller of such Registrable Securities or its counsel;

    

    

    3.1.9 notify the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under the
      Securities Act, of the happening of any event as a result of which the Prospectus included in such Registration Statement, as then in effect, includes a Misstatement, and then to correct such Misstatement as set forth in Section 3.4 hereof;

    

    

    3.1.10 permit a representative of the Holders (such representative to be selected by a majority of the participating Holders), the
      Underwriters, if any, and any attorney or accountant retained by such Holders or Underwriter to participate, at each such person’s own expense, in the preparation of the Registration Statement, and cause the Company’s officers, directors and
      employees to supply all information reasonably requested by any such representative, Underwriter, attorney or accountant in connection with the Registration; provided,
      however, that such representatives or Underwriters enter into a confidentiality agreement, in form and substance reasonably satisfactory to the Company, prior
      to the release or disclosure of any such information;

    

    

    3.1.11 obtain a “cold comfort” letter from the Company’s independent registered public accountants in the event of an Underwritten
      Registration, in customary form and covering such matters of the type customarily covered by “cold comfort” letters as the managing Underwriter may reasonably request, and reasonably satisfactory to a majority-in-interest of the participating
      Holders;

    

    

    
      

      
        

      

    

    3.1.12 on the date the Registrable Securities are delivered for sale pursuant to such Registration, obtain an opinion, dated such date, of
      counsel representing the Company for the purposes of such Registration, addressed to the Holders, the placement agent or sales agent, if any, and the Underwriters, if any, covering such legal matters with respect to the Registration in respect of
      which such opinion is being given as the Holders, placement agent, sales agent, or Underwriter may reasonably request and as are customarily included in such opinions and negative assurance letters, and reasonably satisfactory to a majority in
      interest of the participating Holders;

    

    

    3.1.13 in the event of any Underwritten Offering, enter into and perform its obligations under an underwriting agreement, in usual and
      customary form, with the managing Underwriter of such offering;

    

    

    3.1.14 make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least
      twelve (12) months beginning with the first day of the Company’s first full calendar quarter after the effective date of the Registration Statement which satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any
      successor rule promulgated thereafter by the Commission);

    

    

    3.1.15 if the Registration involves the Registration of Registrable Securities involving gross proceeds in excess of $50,000,000, use its
      reasonable efforts to make available senior executives of the Company to participate in customary “road show” presentations that may be reasonably requested by the Underwriter in any Underwritten Offering; and

    

    

    3.1.16 otherwise, in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the Holders,
      in connection with such Registration.

    

    

    3.2 Registration Expenses. The Registration
      Expenses of all Registrations shall be borne by the Company. It is acknowledged by the Holders that the Holders shall bear all incremental selling expenses relating to the sale of Registrable Securities, such as Underwriters’ commissions and
      discounts, brokerage fees, Underwriter marketing costs and, other than as set forth in the definition of “Registration Expenses,”
      all reasonable fees and expenses of any legal counsel representing the Holders.

    

    

    3.3 Requirements for Participation in Underwritten
          Offerings. No person may participate in any Underwritten Offering for equity securities of the Company pursuant to a Registration initiated by the Company hereunder unless such person (i) agrees to sell such person’s securities on the
      basis provided in any underwriting arrangements approved by the Company and (ii) completes and executes all customary questionnaires, powers of attorney, indemnities, lock-up agreements, underwriting agreements and other customary documents as may be
      reasonably required under the terms of such underwriting arrangements.

    

    

    3.4 Suspension of Sales; Adverse Disclosure.
      Upon receipt of written notice from the Company that a Registration Statement or Prospectus contains a Misstatement, each of the Holders shall forthwith discontinue disposition of Registrable Securities until he, she or it has received copies of a
      supplemented or amended Prospectus correcting the Misstatement (it being understood that the Company hereby covenants to prepare and file such supplement or amendment as soon as practicable after the time of such notice), or until he, she or it is
      advised in writing by the Company that the use of the Prospectus may be resumed. If the filing, initial effectiveness or continued use of a Registration Statement in respect of any Registration at any time would require the Company to make an Adverse
      Disclosure or would require the inclusion in such Registration Statement of financial statements that are unavailable to the Company for reasons beyond the Company’s control, the Company may, upon giving prompt written notice of such action to the
      Holders, delay the filing or initial effectiveness of, or suspend use of, such Registration Statement for the shortest period of time, but in no event more than thirty (30) days, determined in good faith by the Company to be necessary for such
      purpose. In the event the Company exercises its rights under the preceding sentence, the Holders agree to suspend, immediately upon their receipt of the notice referred to above, their use of the Prospectus relating to any Registration in connection
      with any sale or offer to sell Registrable Securities. The Company shall immediately notify the Holders of the expiration of any period during which it exercised its rights under this Section 3.4.

    

    

    
      

      
        

      

    

    3.5 Reporting Obligations. As long as any
      Holder shall own Registrable Securities, the Company, at all times while it shall be a reporting company under the Exchange Act, covenants to file timely (or obtain extensions in respect thereof and file within the applicable grace period) all
      reports required to be filed by the Company after the date hereof pursuant to Sections 13(a) or 15(d) of the Exchange Act and to promptly furnish the Holders with true and complete copies of all such filings. The Company further covenants that it
      shall take such further action as any Holder may reasonably request, all to the extent required from time to time to enable such Holder to sell shares of the Common Stock held by such Holder without registration under the Securities Act within the
      limitation of the exemptions provided by Rule 144 promulgated under the Securities Act (or any successor rule promulgated thereafter by the Commission), including providing any legal opinions, to the extent such exemption is available to Holders at
      such time. Upon the request of any Holder, the Company shall deliver to such Holder a written certification of a duly authorized officer as to whether it has complied with such requirements.

    

    

    ARTICLE IV

    INDEMNIFICATION AND CONTRIBUTION

    

    

    4.1 Indemnification.

    

    

    4.1.1 The Company agrees to indemnify, to the extent permitted by law, each Holder of Registrable Securities, its officers and directors
      and each person who controls such Holder (within the meaning of the Securities Act) against all losses, claims, damages, liabilities and expenses (including attorneys’ fees) caused by any untrue or alleged untrue statement of material fact contained
      in any Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein not
      misleading, except insofar as the same are caused by or contained in any information furnished in writing to the Company by such Holder expressly for use therein. The Company shall indemnify the Underwriters, their officers and directors and each
      person who controls such Underwriters (within the meaning of the Securities Act) to the same extent as provided in the foregoing with respect to the indemnification of the Holder.

    

    

    4.1.2 In connection with any Registration Statement in which a Holder of Registrable Securities is participating, such Holder shall furnish
      to the Company in writing such information and affidavits as the Company reasonably requests for use in connection with any such Registration Statement or Prospectus and, to the extent permitted by law, shall indemnify the Company, its directors and
      officers and agents and each person who controls the Company (within the meaning of the Securities Act) against any losses, claims, damages, liabilities and expenses (including without limitation reasonable attorneys’ fees) resulting from any untrue
      statement of material fact contained in the Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission of a material fact required to be stated therein or necessary to make the
      statements therein not misleading, but only to the extent that such untrue statement or omission is contained in any information or affidavit so furnished in writing by such Holder expressly for use therein; provided, however, that the obligation to indemnify shall be several, not joint and several,
      among such Holders of Registrable Securities, and the liability of each such Holder of Registrable Securities shall be in proportion to and limited to the net proceeds received by such Holder from the sale of Registrable Securities pursuant to such
      Registration Statement. The Holders of Registrable Securities shall indemnify the Underwriters, their officers, directors and each person who controls such Underwriters (within the meaning of the Securities Act) to the same extent as provided in the
      foregoing with respect to indemnification of the Company.

    

    

    4.1.3 Any person entitled to indemnification herein shall (i) give prompt written notice to the indemnifying party of any claim with
      respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s right to indemnification hereunder to the extent such failure has not materially prejudiced the indemnifying party) and (ii)
      unless in such indemnified party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim, permit such indemnifying party to assume the defense of such claim with counsel
      reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its consent (but such consent shall not be
      unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel for all parties indemnified by such indemnifying party
      with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying party shall,
      without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms
      of such settlement) or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.

    

    

    
      

      
        

      

    

    4.1.4 The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by
      or on behalf of the indemnified party or any officer, director or controlling person of such indemnified party and shall survive the transfer of securities. The Company and each Holder of Registrable Securities participating in an offering also
      agrees to make such provisions as are reasonably requested by any indemnified party for contribution to such party in the event the Company’s or such Holder’s indemnification is unavailable for any reason.

    

    

    4.1.5 If the indemnification provided under this Section
          4.1 hereof from the indemnifying party is unavailable or insufficient to hold harmless an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying party, in lieu of
      indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of
      the indemnifying party and the indemnified party, as well as any other relevant equitable considerations. The relative fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any action
      in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made by, or relates to information supplied by, such indemnifying party or indemnified party, and the
      indemnifying party’s and indemnified party’s relative intent, knowledge, access to information and opportunity to correct or prevent such action; provided, however, that the liability of any Holder under this subsection 4.1.5
      shall be limited to the amount of the net proceeds received by such Holder in such offering giving rise to such liability. The amount paid or payable by a party as a result of the losses or other liabilities referred to above shall be deemed to
      include, subject to the limitations set forth in subsections 4.1.1, 4.1.2
      and 4.1.3 above, any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding. The
      parties hereto agree that it would not be just and equitable if contribution pursuant to this subsection 4.1.5 were determined by pro rata allocation or by
      any other method of allocation, which does not take account of the equitable considerations referred to in this subsection 4.1.5. No person guilty of
      fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to this subsection 4.1.5
      from any person who was not guilty of such fraudulent misrepresentation.

    

    

    ARTICLE V

    STOCKHOLDER RIGHTS

    

    

    5.1 Subject to the terms and conditions of this Agreement, at any time and from time to time on or after the date that the Company
      consummates a Business Combination and for so long as the Sponsor holds any Registrable Securities:

    

    

    5.1.1 The Sponsor shall have the right, but not the obligation, to designate three (3) individuals to be appointed or nominated, as the
      case may be, for election to the Board (including any successor, each, a “Nominee”) by giving written notice to the Company on
      or before the time such information is reasonably requested by the Board or the Nominating and Corporate Governance Committee of the Board, as applicable, for inclusion in a proxy statement for a meeting of stockholders.

    

    

    5.1.2 The Company will, as promptly as practicable, use its best efforts to take all necessary and desirable actions (including, without
      limitation, calling special meetings of the Board and the stockholders and recommending, supporting and soliciting proxies) so that there are three Sponsor Directors serving on the Board at all times during which the nomination rights provided in
      Section 5.1.1 are applicable.

    

    

    5.1.3 The Company shall, to the fullest extent permitted by applicable law, use its best efforts to take all actions necessary to ensure
      that: (i) each Nominee is included in the Board’s slate of nominees to the stockholders of the Company for each election of directors; and (ii) each Nominee is included in the proxy statement prepared by management of the Company in connection with
      soliciting proxies for every meeting of the stockholders of the Company called with respect to the election of members of the Board, and at every adjournment or postponement thereof, and on every action or approval by written consent of the
      stockholders of the Company or the Board with respect to the election of members of the Board.

    

    

    
      

      
        

      

    

    5.1.4 If a vacancy occurs because of the death, disability, disqualification, resignation, or removal of a Sponsor Director or for any
      other reason during the period in which rights provided in Section 5.1.1 are applicable, the Sponsor shall be entitled to designate such person’s successor, and the Company will, as promptly as practicable following such designation, use its best
      efforts to take all necessary and desirable actions, to the fullest extent permitted by law, within its control such that such vacancy shall be filled with such successor Nominee.

    

    

    5.1.5 If a Nominee is not elected because of such Nominee’s death, disability, disqualification, withdrawal as a nominee or for any other
      reason, the Sponsor shall be entitled to designate promptly another Nominee and the Company will take all necessary and desirable actions within its control such that the director position for which such Nominee was nominated shall not be filled
      pending such designation.

    

    

    5.1.6 As promptly as reasonably practicable following the request of any Sponsor Director, the Company shall enter into an indemnification
      agreement with such Sponsor Director, in the form entered into with the other members of the Board. The Company shall pay the reasonable, documented out-of-pocket expenses incurred by the Sponsor Director in connection with his or her services
      provided to or on behalf of the Company, including attending meetings or events attended explicitly on behalf of the Company at the Company’s request.

    

    

    5.1.7 The Company shall (i) purchase directors’ and officers’ liability insurance in an amount determined by the Board to be reasonable and
      customary and (ii) for so long as a Sponsor Director serves as a Director of the Company, maintain such coverage with respect to such Sponsor Director; provided
        that upon removal or resignation of such Sponsor Director for any reason, the Company shall take all actions reasonably necessary to extend such directors’ and officers’ liability insurance coverage for a period of not less than six years
      from any such event in respect of any act or omission occurring at or prior to such event.

    

    

    5.1.8 For so long as a Sponsor Director serves as a director of the Company, the Company shall not amend, alter or repeal any right to
      indemnification or exculpation covering or benefiting any director nominated pursuant to this Agreement as and to the extent consistent with applicable law, whether such right is contained in the Company’s certificate of incorporation or bylaws, each
      as amended, or another document (except to the extent such amendment or alteration permits the Company to provide broader indemnification or exculpation rights on a retroactive basis than permitted prior thereto).

    

    

    5.1.9 Any Nominee will be subject to the Company’s customary due diligence process, including its review of a completed questionnaire and a
      background check. Based on the foregoing, the Company may object to any Nominee provided (a) it does so in good faith, and (b) such objection is based upon any of the following: (i) such Nominee was convicted in a criminal proceeding or is a named
      subject of a pending criminal proceeding (excluding traffic violations and other minor offenses), (ii) such Nominee was the subject of any order, judgment, or decree not subsequently reversed, suspended or vacated of any court of competent
      jurisdiction, permanently or temporarily enjoining such proposed director from, or otherwise limiting, the following activities: (A) engaging in any type of business practice, or (B) engaging in any activity in connection with the purchase or sale of
      any security or in connection with any violation of federal or state securities laws, (iii) such Nominee was the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any federal or state authority barring,
      suspending or otherwise limiting for more than 60 days the right of such person to engage in any activity described in clause (ii)(B), or to be associated with persons engaged in such activity, (iv) such proposed director was found by a court of
      competent jurisdiction in a civil action or by the Commission to have violated any federal or state securities law, and the judgment in such civil action or finding by the Commission has not been subsequently reversed, suspended or vacated, or (v)
      such proposed director was the subject of, or a party to any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated, relating to a violation of any federal or state securities
      laws or regulations. In the event the Board reasonably finds the Nominee to be unsuitable based upon one or more of the foregoing clauses (i) through (v) and reasonably objects to the identified director, the Sponsor shall be entitled to propose a
      different nominee to the Board within 30 calendar days of the Company’s notice to Sponsor of its objection to the Nominee and such replacement Nominee shall be subject to the review process outlined above.

    

    

    
      

      
        

      

    

    5.1.10 The Company shall take all necessary action to cause a Sponsor Director chosen by the Sponsor to be elected to the board of
      directors (or similar governing body) of each material operating subsidiary of the Company to the extent requested by the Sponsor. Such Sponsor Director shall have the right to attend (in person or remotely) any meetings of the board of directors (or
      similar governing body or committee thereof) of each subsidiary of the Company.

    

    

    ARTICLE VI

    MISCELLANEOUS

    

    

    6.1 Notices. Any notice or communication under
      this Agreement must be in writing and given by (i) deposit in the United States mail, addressed to the party to be notified, postage prepaid and registered or certified with return receipt requested, (ii) delivery in person or by courier service
      providing evidence of delivery, or (iii) transmission by hand delivery, electronic mail, telecopy, telegram or facsimile. Each notice or communication that is mailed, delivered, or transmitted in the manner described above shall be deemed
      sufficiently given, served, sent, and received, in the case of mailed notices, on the third business day following the date on which it is mailed and, in the case of notices delivered by courier service, hand delivery, electronic mail, telecopy,
      telegram or facsimile, at such time as it is delivered to the addressee (with the delivery receipt or the affidavit of messenger) or at such time as delivery is refused by the addressee upon presentation. Any notice or communication under this
      Agreement must be addressed, if to the Company, to: 7809 Woodmont Avenue, Suite 200, Bethesda, MD 20814, Attention: Joshua Lynn, with copy to: Ropes & Gray LLP, Ropes & Gray LLP, 1211 Avenue of the Americas, New York, NY 10036, Attention:
      Paul Tropp and Christopher Capuzzi, and, if to any Holder, at such Holder’s address or facsimile number as set forth in the Company’s books and records. Any party may change its address for notice at any time and from time to time by written notice
      to the other parties hereto, and such change of address shall become effective thirty (30) days after delivery of such notice as provided in this Section 6.1.

    

    

    6.2 Assignment; No Third Party Beneficiaries.

    

    

    6.2.1 This Agreement and the rights, duties and obligations of the Company hereunder may not be assigned or delegated by the Company in
      whole or in part.

    

    

    6.2.2 Prior to the expiration of the Founder Shares Lock-Up Period or the Private Placement Lock-Up Period, as the case may be, no Holder
      may assign or delegate such Holder’s rights, duties or obligations under this Agreement, in whole or in part, except in connection with a transfer of Registrable Securities by such Holder to a Permitted Transferee, but only if such Permitted
      Transferee agrees to become bound by the transfer restrictions set forth in this Agreement and other applicable agreements.

    

    

    6.2.3 This Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its
      successors and the permitted assigns of the Holders, which shall include Permitted Transferees.

    

    

    6.2.4 This Agreement shall not confer any rights or benefits on any persons that are not parties hereto, other than as expressly set forth
      in this Agreement and this Section 6.2.

    

    

    6.2.5 No assignment by any party hereto of such party’s rights, duties and obligations hereunder shall be binding upon or obligate the
      Company unless and until the Company shall have received (i) written notice of such assignment as provided in Section 6.1 hereof and (ii) the written
      agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms and provisions of this Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement). Any transfer or assignment
      made other than as provided in this Section 6.2 shall be null and void.

    

    

    6.3 Severability. This Agreement shall be
      deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or
      unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible that is valid and enforceable.

    

    

    
      

      
        

      

    

    6.4 Counterparts. This Agreement may be
      executed in multiple counterparts (including facsimile or PDF counterparts), each of which shall be deemed an original, and all of which together shall constitute the same instrument, but only one of which need be produced. A signed copy of this
      Agreement delivered by facsimile, e-mail or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy of this Agreement.

    

    

    6.5 Entire Agreement. This Agreement (including
      all agreements entered into pursuant hereto and all certificates and instruments delivered pursuant hereto and thereto) constitute the entire agreement of the parties with respect to the subject matter hereof and supersede all prior and
      contemporaneous agreements, representations, understandings, negotiations and discussions between the parties, whether oral or written.

    

    

    6.6 Governing Law; Venue. NOTWITHSTANDING THE
      PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES EXPRESSLY AGREE THAT (I) THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF NEW YORK AS APPLIED TO AGREEMENTS AMONG NEW YORK RESIDENTS
      ENTERED INTO AND TO BE PERFORMED ENTIRELY WITHIN NEW YORK, WITHOUT REGARD TO THE CONFLICT OF LAW PROVISIONS OF SUCH JURISDICTION AND (II) THE VENUE FOR ANY ACTION TAKEN WITH RESPECT TO THIS AGREEMENT SHALL BE ANY STATE OR FEDERAL COURT IN NEW YORK
      COUNTY IN THE STATE OF NEW YORK.

    

    

    6.7 Waiver of Trial by Jury. Each party hereby
      irrevocably and unconditionally waives the right to a trial by jury in any action, suit, counterclaim or other proceeding (whether based on contract, tort or otherwise) arising out of, connected with or relating to this Agreement, the transactions
      contemplated hereby, or the actions of the Sponsor in the negotiation, administration, performance or enforcement hereof.

    

    

    6.8 Amendments and Modifications. Upon the
      written consent of the Company and the Holders of at least a majority in interest of the Registrable Securities at the time in question, compliance with any of the provisions, covenants and conditions set forth in this Agreement may be waived, or any
      of such provisions, covenants or conditions may be amended or modified; provided, however, that notwithstanding the foregoing, (a) any amendment hereto or waiver hereof that adversely affects one Holder, solely in his, her or its capacity as a holder of the shares of capital stock of the Company, in a
      manner that is materially different from the other Holders (in such capacity) shall require the consent of the Holder so affected and (b) any amendment hereto or waiver hereof that adversely affects the rights of the Anchor Investor shall require the
      consent of the Anchor Investor. No course of dealing between any Holder or the Company and any other party hereto or any failure or delay on the part of a Holder or the Company in exercising any rights or remedies under this Agreement shall operate
      as a waiver of any rights or remedies of any Holder or the Company. No single or partial exercise of any rights or remedies under this Agreement by a party shall operate as a waiver or preclude the exercise of any other rights or remedies hereunder
      or thereunder by such party.

    

    

    6.9 Titles and Headings. Titles and headings of
      sections of this Agreement are for convenience only and shall not affect the construction of any provision of this Agreement.

    

    

    6.10 Remedies Cumulative. In the event that the
      Company fails to observe or perform any covenant or agreement to be observed or performed under this Agreement, the Holders may proceed to protect and enforce its rights by suit in equity or action at law, whether for specific performance of any term
      contained in this Agreement or for an injunction against the breach of any such term or in aid of the exercise of any power granted in this Agreement or to enforce any other legal or equitable right, or to take any one or more of such actions,
      without being required to post a bond. None of the rights, powers or remedies conferred under this Agreement shall be mutually exclusive, and each such right, power or remedy shall be cumulative and in addition to any other right, power or remedy,
      whether conferred by this Agreement or now or hereafter available at law, in equity, by statute or otherwise.

    

    

    6.11 Other Registration Rights. The Company
      represents and warrants that no person, other than a Holder of Registrable Securities, has any right to require the Company to register any securities of the Company for sale or to include such securities of the Company in any Registration filed by
      the Company for the sale of securities for its own account or for the account of any other person. Further, the Company represents and warrants that this Agreement supersedes any other registration rights agreement or agreement with similar terms and
      conditions and in the event of a conflict between any such agreement or agreements and this Agreement, the terms of this Agreement shall prevail.

    

    

    6.12 Term. This Agreement shall terminate upon
      the earlier of (i) the tenth anniversary of the date of this Agreement or (ii) the date as of which (A) all of the Registrable Securities have been sold pursuant to a Registration Statement (but in no event prior to the applicable period referred to
      in Section 4(a)(3) of the Securities Act and Rule 174 thereunder (or any successor rule promulgated thereafter by the Commission)) or (B) the Holders of all of the Registrable Securities are permitted to sell the Registrable Securities under Rule 144
      (or any similar provision) under the Securities Act without limitation on the amount of securities sold or the manner of sale. The provisions of Section 3.5
      and Article IV shall survive any termination.

    

    

    [SIGNATURE PAGES FOLLOW]

    

    

    
      

      
        

      

    

    IN WITNESS WHEREOF, the undersigned
      have caused this Agreement to be executed as of the date first written above.

    

    

    	 	
            COMPANY:

          
	 	 
	 	
            HEALTHCARE SERVICES ACQUISITION CORPORATION

          
	 	 
	 	
            By:

          	
            /s/ Joshua B. Lynn

          
	 	
            Name:

          	
             Joshua B. Lynn

          
	 	
            Title:

          	
            Chief Financial Officer

          
	 	 	 
	 	 	 
	 	
            HOLDERS:

          
	 	 
	 	
            HEALTHCARE SERVICES ACQUISITION HOLDINGS LLC

          
	 	 
	 	
            By:

          	
            /s/ Joshua B. Lynn

          
	 	
            Name:

          	
             Joshua B. Lynn

          
	 	
            Title:

          	
            Chief Financial Officer

          
	 	 
	 	
            BLACKROCK CREDIT ALPHA MASTER FUND L.P.

            By: BlackRock Financial Management Inc., in its capacity as investment advisor

          
	 	 
	 	
            By:

          	
            /s/ Christopher Biasotti

          
	 	
            Name:

          	
             Christopher Biasotti

          
	 	
            Title:

          	
            Authorized Signatory

          
	 	 
	 	
            THE OBSIDIAN MASTER FUND

            By: BlackRock Financial Management Inc., in its capacity as investment advisor

          
	 	 
	 	
            By:

          	
            /s/ Christopher Biasotti

          
	 	
            Name:

          	
             Christopher Biasotti

          
	 	
            Title:

          	
            Authorized Signatory

          
	 	
            HC NCBR FUND

            By: BlackRock Financial Management Inc., in its capacity as investment advisor

          
	 	 
	 	
            By:

          	
            /s/ Christopher Biasotti

          
	 	
            Name:

          	
             Christopher Biasotti

          
	 	
            Title:

          	
            Authorized Signatory

          
	 	 	 
	 	 	
            /s/ Jeanne L. Manischewitz

          
	 	
            Name:

          	
            Jeanne L. Manischewitz

          
	 	 
	 	 	
            /s/ Brian T. Griffin

          
	 	
            Name:

          	
            Brian T. Griffin

          
	 	 
	 	 	
            /s/ Michael P. Donovan

          
	 	
            Name:

          	
            Michael P. DonovanExhibit 10.4

    

    

    December 22, 2020

    

    

    Healthcare Services Acquisition Corporation

    7809 Woodmont Avenue, Suite 200

    Bethesda, MD 20814

    

    

    Re:          Initial Public Offering

    

    

    Ladies and Gentlemen:

    

    

    This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) to be entered into by and among Healthcare Services Acquisition Corporation, a Delaware corporation (the “Company”), and B. Riley
      Securities, Inc., as underwriter (the “Underwriter”), relating to an underwritten initial public offering (the “Public Offering”),
      of 28,800,000 of the Company’s units (including up to 4,320,000 units that may be purchased by the Underwriter to cover over-allotments, if any) (the “Units”), each comprising one share of
      the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), and one-half of one redeemable warrant. Each whole warrant (each, a “Warrant”) entitles the holder thereof to purchase one share of Common Stock at a price of $11.50 per share, subject to adjustment. The Units will be sold in the Public Offering pursuant to a registration statement on
      Form S-1 and a prospectus (the “Prospectus”), filed by the Company with the U.S. Securities and Exchange Commission (the “Commission”)
      and the Company has applied to have the Units listed on the Nasdaq Capital Market. Certain capitalized terms used herein are defined in paragraph 13 hereof.

    

    

    In order to induce the Company and the Underwriter to enter into the Underwriting Agreement and to proceed with the Public Offering and for other good and valuable consideration, the receipt and sufficiency of which
      are hereby acknowledged, each of the Sponsor and the undersigned individuals, each of whom is a member of the Company’s board of directors and/or management team (each, an “Insider” and
      collectively, the “Insiders”), hereby agrees with the Company as follows:

    

    

    	

          	1.	
            It is acknowledged and agreed that the Company shall not enter into a definitive agreement regarding a proposed Business Combination without the prior consent of the Sponsor.

          

    

    

    	

          	2.	
            The Sponsor and each Insider hereby agrees that in the event that the Company fails to consummate a Business Combination within 24 months from the closing of the Public Offering, or such later period approved by the Company’s stockholders
              in accordance with the Company’s amended and restated certificate of incorporation (the “Charter”), the Sponsor and each Insider shall take all reasonable steps to cause the Company
              to (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than 10 business days thereafter, subject to lawfully available funds therefor, redeem 100% of the Common Stock sold as
              part of the Units in the Public Offering (the “Offering Shares”), at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account (as
              defined below), including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the
              number of then outstanding Offering Shares, which redemption will completely extinguish all Public Stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law; and
              (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s
              obligations under Delaware law to provide for claims of creditors and other requirements of applicable law. The Sponsor and each Insider agrees not to propose any amendment to the Charter to (a) modify the substance or timing of the Company’s
              obligation to allow redemption in connection with a Business Combination or to redeem 100% of the Offering Shares if the Company does not complete a Business Combination within the time period set forth in the Charter or (b) with respect to
              any other provision relating to stockholders’ rights or pre-initial Business Combination activity, unless the Company provides Public Stockholders with the opportunity to redeem their shares of Common Stock upon approval of any such amendment
              at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise and
              income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Offering Shares.

          

    
      
        

    

    
    The Sponsor and each Insider acknowledges that it, he or she has no right, title, interest or claim of any kind in or to any monies held in the Trust Account or any other asset of the Company as a
      result of any liquidation of the Company with respect to the Founder Shares held by it, him or her. The Sponsor and each Insider hereby agrees that if the Company seeks stockholder approval of a proposed Business Combination, then in connection with
      such proposed Business Combination, it, he or she shall vote any shares of Capital Stock owned by it, him or her in favor of any proposed Business Combination.  The Sponsor and each Insider hereby waives, with respect to any shares of Capital Stock
      held by it, him or her, if any, any redemption rights it, he or she may have in connection with the consummation of a Business Combination, including, without limitation, any such rights available in the context of (i) a stockholder vote to approve
      such Business Combination, or (ii) a stockholder vote to approve an amendment to the Charter to (a) modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the
      Offering Shares if the Company does not complete a Business Combination within the time period set forth in the Charter or (b) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity (although
      the Sponsor and the Insiders shall be entitled to liquidation rights with respect to any Offering Shares it or they hold if the Company fails to consummate a Business Combination within the time period set forth in the Charter). If the Company
      engages in a tender offer in connection with any proposed Business Combination, the Sponsor and each Insider agrees that it, he or she will not seek to sell its, his or her shares of Common Stock to the Company in connection with such tender offer.

    

    

    	

          	3.	
            The undersigned acknowledges and agrees that prior to entering into a definitive agreement for a Business Combination with a target business that is affiliated with the undersigned or any other Insiders of the Company or their affiliates,
              such transaction must be approved by a majority of the Company’s disinterested independent directors and the Company must, to the extent required by applicable law or the Company’s board of directors, obtain an opinion from an independent
              investment banking firm or an independent accounting firm that such Business Combination is fair to the Company from a financial point of view.

          

    

    

    	

          	4.	
            During the period commencing on the effective date of the Underwriting Agreement and ending 180 days after such date, the Sponsor and each Insider shall not, without the prior written consent of the Underwriter, (i) sell, offer to sell,
              contract or agree to sell, hypothecate, pledge, grant any option to purchase or otherwise dispose of or agree to dispose of, directly or indirectly, or establish or increase a put equivalent position or liquidate or decrease a call equivalent
              position within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations of the Commission promulgated
              thereunder, with respect to any Units, shares of Common Stock, Founder Shares, Warrants or any securities convertible into, or exercisable, or exchangeable for, shares of Common Stock (but excluding Units and shares of Common Stock purchased
              in the Public Offering or thereafter) owned by it, him or her, (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Units, shares of Common Stock,
              Founder Shares, Warrants or any securities convertible into, or exercisable, or exchangeable for, shares of Common Stock owned by it, him or her, whether any such transaction is to be settled by delivery of such securities, in cash or
              otherwise, or (iii) publicly announce any intention to effect any transaction specified in clause (i) or (ii). The provisions of this paragraph will not apply if the release or waiver is effected solely to permit a transfer not for
              consideration and the transferee has agreed in writing to be bound by the same terms described in this Letter Agreement to the extent and for the duration that such terms remain in effect at the time of the transfer.

          

    
      2

      
        

    

    	

          	5.	
            In the event of the liquidation of the Trust Account upon the failure of the Company to consummate its initial Business Combination within the time period set forth in the Charter, the Sponsor (the “Indemnitor”), which for purposes of clarification shall not extend to any other shareholders, members or managers of the Sponsor, or any of the other undersigned, agrees to indemnify and hold harmless the Company
              against any and all loss, liability, claim, damage and expense whatsoever (including, but not limited to, any and all legal or other expenses reasonably incurred in investigating, preparing or defending against any litigation, whether pending
              or threatened) to which the Company may become subject as a result of any claim by (i) any third party for services rendered or products sold to the Company or (ii) any prospective target business with which the Company has entered into a
              written letter of intent, confidentiality or other similar agreement or Business Combination agreement (a “Target”); provided, however, that such indemnification of
              the Company by the Indemnitor shall (x) apply only to the extent necessary to ensure that such claims by a third party for services rendered (other than the Company’s independent public accountants) or products sold to the Company or a Target
              do not reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Offering Share and (ii) the actual amount per Offering Share held in the Trust Account as of the date of the liquidation of the Trust Account, if
              less than $10.00 per Offering Share is then held in the Trust Account due to reductions in the value of the trust assets, less interest earned on the funds in the Trust Account which may be withdrawn to pay franchise and income taxes, (y) not
              apply to any claims by a third party or a Target which executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) and (z) not apply to any claims under the Company’s indemnity
              of the Underwriter against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that any such executed waiver
              is deemed to be unenforceable against such third party, the Indemnitor shall not be responsible to the extent of any liability for such third party claims. The Indemnitor shall have the right to defend against any such claim with counsel of
              its choice reasonably satisfactory to the Company if, within 15 days following written receipt of notice of the claim to the Indemnitor, the Indemnitor notifies the Company in writing that it shall undertake such defense.

          

    

    

    	

          	6.	
            To the extent that the Underwriter does not exercise its over-allotment option to purchase up to an additional 4,320,000 Units within 45 days from the date of the Prospectus (and as further described in the Prospectus) in full, the Sponsor
              agrees to forfeit, at no cost, a number of Founder Shares in the aggregate equal to 1,080,000 multiplied by a fraction (i) the numerator of which is 4,320,000 minus the number of Units purchased by the Underwriter upon the exercise of their
              over-allotment option, and (ii) the denominator of which is 4,320,000. For clarity, the forfeiture shall yield the result that the Initial Stockholders will own an aggregate of 20% of the Company’s issued and outstanding shares of Capital
              Stock after the Public Offering (assuming, for purposes of this calculation, that the Initial Stockholders do not purchase any Units in the Public Offering).

          

    

    

    	

          	7.	
            The Sponsor and each Insider hereby agrees and acknowledges that: (i) the Underwriter and the Company would be irreparably injured in the event of a breach by such Sponsor or an Insider of its, his or her obligations under paragraphs 2, 3,
              4, 5, 6, 8(a), 8(b) and, solely as to each D&O Insider, 9, as applicable, of this Letter Agreement, (ii) monetary damages may not be an adequate remedy for such breach and (iii) the non-breaching party shall be entitled to injunctive
              relief, in addition to any other remedy that such party may have in law or in equity, in the event of such breach.

          

    

    

    
      
        	

              	8.          	(a)          	The Sponsor and each Insider agrees that it, he or she shall not Transfer any Founder Shares (or shares of Common Stock issuable upon conversion thereof) until the earlier of
                (A) one year after the completion of the Company’s initial Business Combination or (B) subsequent to the Business Combination, (x) if the last sale price of the Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits,
                stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination or (y) the date on which the Company
                completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of Common Stock for cash, securities or other
                property (the “Founder Shares Lock-up Period”).

      

    

    

    

    (b)          The Sponsor and each Insider agrees that it, he or she shall not Transfer any Private Placement Warrants (or shares of Common Stock issued or issuable upon the exercise of the Private
      Placement Warrants), until 30 days after the completion of the Company’s initial Business Combination (the “Private Placement Warrants Lock-up Period”, together with the Founder Shares
      Lock-up Period, the “Lock-up Periods”).

    
      3

      
        

    

    (c)          Notwithstanding the provisions set forth in paragraphs 8(a) and (b), Transfers of the Founder Shares, Private Placement Warrants and shares of Common Stock issued or issuable upon the
      exercise or conversion of the Private Placement Warrants or the Founder Shares and that are held by the Sponsor, any Insider or any of their permitted transferees (that have complied with this paragraph 8(c)), are permitted (a) to the Company’s
      officers or directors, any affiliates or family members of any of the Company’s officers or directors, the Sponsor, any members of the Sponsor, any affiliates of the Sponsor, any affiliates of such members and funds and accounts advised by such
      members; (b) in the case of an individual, by gift to a member of such individual’s immediate family or to a trust, the beneficiary of which is a member of such individual’s immediate family, an affiliate of such individual or to a charitable
      organization; (c) in the case of an individual, by virtue of the laws of descent and distribution upon death of such person; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in
      connection with the consummation of an initial Business Combination at prices no greater than the price at which the securities were originally purchased; (f) to an entity that is an affiliate of such person; (g) in the event of the Company’s
      liquidation prior to the completion of an initial Business Combination; (h) by virtue of the laws of the State of Delaware or the Sponsor’s limited liability company agreement upon dissolution of the Sponsor; (i) in the event of the Company’s
      liquidation, merger, capital stock exchange, reorganization or other similar transaction which results in all of the Company’s stockholders having the right to exchange their shares of Common Stock for cash, securities or other property subsequent to
      the completion of an initial Business Combination; or (j) to the Company for no value for cancellation in connection with the consummation of an initial Business Combination; provided, however, that, in the case of clauses (a) through (f) or (h),
      these permitted transferees must enter into a written agreement with the Company agreeing to be bound by the transfer restrictions herein.

    

    

    	

          	9.	
            Each of the Insiders who is or is nominated to be a director or officer of the Company (each, a “D&O Insider”) agrees to serve in such capacity until the earlier of the
              consummation by the Company of an initial Business Combination, the liquidation of the Company, or his or her removal, death or incapacity. The Sponsor and each D&O Insider represents and warrants that it, he or she has never been
              suspended or expelled from membership in any securities or commodities exchange or association or had a securities or commodities license or registration denied, suspended or revoked. Each D&O Insider’s biographical information furnished
              to the Company (including any such information included in the Prospectus) is true and accurate in all material respects and does not omit any material information with respect to the D&O Insider’s background and contains all of the
              information required to be disclosed pursuant to Item 401 of Regulation S-K, promulgated under the Securities Act. Each D&O Insider’s questionnaire furnished to the Company and the Underwriter is true and accurate in all material
              respects. Each D&O Insider represents and warrants that: it, he or she is not subject to or a respondent in any legal action for, any injunction, cease-and-desist order or order or stipulation to desist or refrain from any act or practice
              relating to the offering of securities in any jurisdiction; it, he or she has never been convicted of, or pleaded guilty to, any crime (i) involving fraud; (ii) relating to any financial transaction or handling of funds of another person; or
              (iii) pertaining to any dealings in any securities and it, he or she is not currently a defendant in any such criminal proceeding.

          

    

    

    	

          	10.	
            Except as disclosed in the Prospectus, neither the Sponsor nor any Insider, nor any affiliate of the Sponsor or any Insider, shall receive from the Company any finder’s fee, reimbursement, consulting fee, monies in respect of any repayment
              of a loan or other compensation prior to, or in connection with any services rendered in order to effectuate, the consummation of the Company’s initial Business Combination (regardless of the type of transaction that it is).

          

    

    

    	

          	11.	
            The Company, the Sponsor and each Insider represents and warrants, severally and not jointly, that it, he or she has full right and power, without violating any agreement to which it, he or she is bound (including, without limitation, any
              non-competition or non-solicitation agreement with any employer or former employer), to enter into this Letter Agreement and, as applicable, to serve as an officer and/or director on the board of directors of the Company and hereby consents
              to being named in the Prospectus as an officer and/or director of the Company.

          

    
      4

      
        

    

    	

          	12.	
            As used herein, (i) “Business Combination” shall mean a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination,
              involving the Company and one or more businesses; (ii) ”Capital Stock” shall mean, collectively, the Common Stock and the Founder Shares; (iii) ”Founder Shares” shall mean the 8,280,000 shares of the Company’s Class B common stock, par value $0.0001 per share, issued and outstanding immediately prior to the consummation of the Public Offering (up to
              1,080,000 shares of which are subject to complete or partial forfeiture by the Sponsor if the over-allotment option is not exercised in full by the Underwriter); (iv) ”Initial Stockholders”
              shall mean the Sponsor and any Insider that holds Founder Shares; (v) “Private Placement Warrants” shall mean the Warrants to purchase up to 7,760,000 shares of Common Stock of the
              Company (or 8,624,000 shares of Common Stock if the over-allotment option is exercised in full by the Underwriter) that the Sponsor and certain funds and accounts managed by BlackRock, Inc. have agreed to purchase for an aggregate purchase
              price of $7,760,000 (or $8,624,000 if the over-allotment option is exercised in full by the Underwriter), or $1.00 per Warrant, in a private placement that shall occur simultaneously with the consummation of the Public Offering; (vi) “Public Stockholders” shall mean the holders of securities issued in the Public Offering; (vii) “Trust Account” shall mean the
              trust account into which the net proceeds of the Public Offering and certain proceeds from the sale of the Private Placement Warrants shall be deposited; and (viii) ”Transfer” shall
              mean the (a) sale of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option to purchase or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put
              equivalent position or liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Exchange Act, and the rules and regulations of the Commission promulgated thereunder with respect to, any
              security, (b) entry into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such
              securities, in cash or otherwise, or (c) public announcement of any intention to effect any transaction specified in clause (a) or (b).

          

    

    

    	

          	13.	
            The Company will maintain an insurance policy or policies providing directors’ and officers’ liability insurance, and each D&O Insider shall be covered by such policy or policies, in accordance with its or their terms, to the maximum
              extent of the coverage available for any of the Company’s directors or officers.

          

    

    

    	

          	14.	
            This Letter Agreement constitutes the entire agreement and understanding of the parties hereto in respect of the subject matter hereof and supersedes all prior understandings, agreements, or representations by or among the parties hereto,
              written or oral, to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby. This Letter Agreement may not be changed, amended, modified or waived (other than to correct a typographical error) as
              to any particular provision, except by a written instrument executed by all parties hereto.

          

    

    

    	

          	15.	
            No party hereto may assign either this Letter Agreement or any of its rights, interests, or obligations hereunder without the prior written consent of the other parties. Any purported assignment in violation of this paragraph shall be void
              and ineffectual and shall not operate to transfer or assign any interest or title to the purported assignee. This Letter Agreement shall be binding on the Company, the Sponsor and each Insider and their respective successors, heirs and
              assigns and permitted transferees.

          

    

    

    	

          	16.	
            Nothing in this Letter Agreement shall be construed to confer upon, or give to, any person or corporation other than the parties hereto any right, remedy or claim under or by reason of this Letter Agreement or of any covenant, condition,
              stipulation, promise or agreement hereof. All covenants, conditions, stipulations, promises and agreements contained in this Letter Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors, heirs,
              personal representatives and assigns and permitted transferees.

          

    
      5

      
        

    

    	

          	17.	
            This Letter Agreement may be executed in any number of original, facsimile or other electronic counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together
              constitute but one and the same instrument.

          

    

    

    	

          	18.	
            This Letter Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Letter Agreement or of any other term or provision hereof.
              Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Letter Agreement a provision as similar in terms to such invalid or unenforceable provision as
              may be possible and be valid and enforceable.

          

    

    

    	

          	19.	
            This Letter Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Delaware, without giving effect to conflicts of law principles that would result in the application of the substantive laws
              of another jurisdiction. The parties hereto (i) all agree that any action, proceeding, claim or dispute arising out of, or relating in any way to, this Letter Agreement shall be brought and enforced in the courts of Wilmington, in the State
              of Delaware, and irrevocably submit to such jurisdiction and venue, which jurisdiction and venue shall be exclusive and (ii) waive any objection to such exclusive jurisdiction and venue or that such courts represent an inconvenient forum.

          

    

    

    	

          	20.	
            Any notice, consent or request to be given in connection with any of the terms or provisions of this Letter Agreement shall be in writing and shall be sent by express mail or similar private courier service, by certified mail (return
              receipt requested), by hand delivery or facsimile or e-mail transmission.

          

    

    

    	

          	21.	
            This Letter Agreement shall terminate on the earlier of (i) the expiration of the Lock-up Periods or (ii) the liquidation of the Company; provided that paragraph 5 of this Letter Agreement shall survive such liquidation.

          

    
      6

      
        

    

    	 	
            Sincerely,

          
	 
	
            HEALTHCARE SERVICES ACQUISITION HOLDINGS LLC

          
	 
	 
	
            By:

          	
            /s/ Joshua B. Lynn

          
	 	
            Name: Joshua B. Lynn

          
	 	
            Title: Chief Financial Officer

          

    

    

    	 	
            /s/ David T. Blair

          
	
            David T. Blair

          
	 	 
	 	
            /s/ Martin J. Payne

          
	
            Martin J. Payne

          
	 	 
	 	
            /s/ Joshua B. Lynn

          
	
            Joshua B. Lynn

          
	 	 
	 	
            /s/ Tao Tan

          
	
            Tao Tan

          
	 	 
	 	
            /s/ Michael P. Donovan

          
	
            Michael P. Donovan

          
	 	 
	 	
            /s/ Brian T. Griffin

          
	
            Brian T. Griffin

          
	 	 
	 	
            /s/ Jeanne L. Manischewitz

          
	
            Jeanne L. Manischewitz

          

    

    

    	
            Acknowledged and Agreed:

          	 
	 	 
	
            HEALTHCARE SERVICES ACQUISITION CORPORATION

          	 
	 	 
	 	 
	
            By:

          	
            /s/ Joshua B. Lynn

          	 
	 	
            Name: Joshua B. Lynn

          	 
	 	
            Title: Chief Financial Officer

          	 

    

    

    [Signature Page to Insider Letter]

     

    

  

  7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}]]